Literature DB >> 28395794

Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program.

Mark Rosen1, Paul E Kinahan2, James F Gimpel3, Adam Opanowski4, Barry A Siegel5, G Craig Hill6, Linda Weiss7, Lalitha Shankar8.   

Abstract

We present an overview of the Centers for Quantitative Imaging Excellence (CQIE) program, which was initiated in 2010 to establish a resource of clinical trial-ready sites within the National Cancer Institute (NCI)-designated Cancer Centers (NCI-CCs) network. The intent was to enable imaging centers in the NCI-CCs network capable of conducting treatment trials with advanced quantitative imaging end points. We describe the motivations for establishing the CQIE, the process used to initiate the network, the methods of site qualification for positron emission tomography, computed tomography, and magnetic resonance imaging, and the results of the evaluations over the subsequent 3 years.
Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Scanner qualification; cancer imaging; clinical trials; imaging accreditation; imaging credentialing; phantom imaging

Mesh:

Year:  2016        PMID: 28395794      PMCID: PMC5389125          DOI: 10.1016/j.acra.2016.09.025

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  16 in total

1.  Variability in PET quantitation within a multicenter consortium.

Authors:  Frederic H Fahey; Paul E Kinahan; Robert K Doot; Mehmet Kocak; Harold Thurston; Tina Young Poussaint
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

2.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

3.  A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging.

Authors:  Andrew J Buckler; Linda Bresolin; N Reed Dunnick; Daniel C Sullivan
Journal:  Radiology       Date:  2011-03       Impact factor: 11.105

4.  Clinical trials in molecular imaging: the importance of following the protocol.

Authors:  LisaAnn Trembath; Adam Opanowski
Journal:  J Nucl Med Technol       Date:  2011-05-12

5.  Design considerations for using PET as a response measure in single site and multicenter clinical trials.

Authors:  Robert K Doot; Brenda F Kurland; Paul E Kinahan; David A Mankoff
Journal:  Acad Radiol       Date:  2011-11-21       Impact factor: 3.173

Review 6.  The clinical evaluation of novel imaging methods for cancer management.

Authors:  Lalitha K Shankar
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

Review 7.  Quantitative Imaging in Cancer Clinical Trials.

Authors:  Thomas E Yankeelov; David A Mankoff; Lawrence H Schwartz; Frank S Lieberman; John M Buatti; James M Mountz; Bradley J Erickson; Fiona M M Fennessy; Wei Huang; Jayashree Kalpathy-Cramer; Richard L Wahl; Hannah M Linden; Paul E Kinahan; Binsheng Zhao; Nola M Hylton; Robert J Gillies; Laurence Clarke; Robert Nordstrom; Daniel L Rubin
Journal:  Clin Cancer Res       Date:  2016-01-15       Impact factor: 12.531

8.  Biomedical research: increasing value, reducing waste.

Authors:  Malcolm R Macleod; Susan Michie; Ian Roberts; Ulrich Dirnagl; Iain Chalmers; John P A Ioannidis; Rustam Al-Shahi Salman; An-Wen Chan; Paul Glasziou
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

9.  Future vision for the quality assurance of oncology clinical trials.

Authors:  Thomas J Fitzgerald; Maryann Bishop-Jodoin; Walter R Bosch; Walter J Curran; David S Followill; James M Galvin; Richard Hanusik; Steven R King; Michael V Knopp; Fran Laurie; Elizabeth O'Meara; Jeff M Michalski; Joel H Saltz; Mitchell D Schnall; Lawrence Schwartz; Kenneth Ulin; Ying Xiao; Marcia Urie
Journal:  Front Oncol       Date:  2013-03-15       Impact factor: 6.244

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  6 in total

Review 1.  NCTN Assessment on Current Applications of Radiomics in Oncology.

Authors:  Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-01-31       Impact factor: 7.038

2.  Multicenter survey of PET/CT protocol parameters that affect standardized uptake values.

Authors:  Darrin Byrd; Rebecca Christopfel; John Buatti; Eduardo Moros; Sadek Nehmeh; Adam Opanowski; Paul Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2017-12-08

Review 3.  Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.

Authors:  Joshua S Scheuermann; Janet S Reddin; Adam Opanowski; Paul E Kinahan; Barry A Siegel; Lalitha K Shankar; Joel S Karp
Journal:  J Nucl Med       Date:  2017-03-02       Impact factor: 10.057

Review 4.  Radiomic Analysis: Study Design, Statistical Analysis, and Other Bias Mitigation Strategies.

Authors:  Chaya S Moskowitz; Mattea L Welch; Michael A Jacobs; Brenda F Kurland; Amber L Simpson
Journal:  Radiology       Date:  2022-05-17       Impact factor: 29.146

5.  Performance evaluation of the next generation solid-state digital photon counting PET/CT system.

Authors:  Jun Zhang; Piotr Maniawski; Michael V Knopp
Journal:  EJNMMI Res       Date:  2018-11-06       Impact factor: 3.138

Review 6.  Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.

Authors:  Amita Shukla-Dave; Nancy A Obuchowski; Thomas L Chenevert; Sachin Jambawalikar; Lawrence H Schwartz; Dariya Malyarenko; Wei Huang; Susan M Noworolski; Robert J Young; Mark S Shiroishi; Harrison Kim; Catherine Coolens; Hendrik Laue; Caroline Chung; Mark Rosen; Michael Boss; Edward F Jackson
Journal:  J Magn Reson Imaging       Date:  2018-11-19       Impact factor: 5.119

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.